5-MeO-MALT

5-MeO-MALT, also known as 5-methoxy-N-methyl-N-allyltryptamine, is a psychedelic drug of the tryptamine family related to 5-MeO-DALT.

5-MeO-MALT was first described in the literature in 2004. It was encountered as a novel designer drug in 2014.EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2015) New psychoactive substances in Europe - an update from the EU Early Warning System. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/ 2015/new-psychoactive-substances. Accessed 15 Nov 2015 The drug's pharmacology was studied and described in greater detail in 2024.

Use and effects 5-MeO-MALT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).

Interactions

Pharmacology Pharmacodynamics The pharmacology of 5-MeO-MALT has been studied. It is a potent serotonin 5-HT2A receptor agonist and produces the head-twitch response in rodents. The drug also shows high affinity for the serotonin 5-HT1A receptor.

Chemistry Analogues Analogues of 5-MeO-MALT include methylallyltryptamine (MALT), 4-HO-MALT (maltocin), 4-AcO-MALT, 5-MeO-DMT, 5-MeO-DET, 5-MeO-DPT, 5-MeO-DiPT, 5-MeO-DALT, 5-MeO-MET, 5-MeO-MPT, 5-MeO-MiPT, 5-MeO-EiPT, and 5-MeO-iPALT (ASR-3001), among others.

Society and culture Legal status Canada 5-MeO-MALT is not a controlled substance in Canada as of 2025.

Hungary 5-MeO-MALT is illegal in Hungary.

Sweden Sweden's public health agency suggested classifying 5-MeO-MALT as a hazardous substance, on May 15, 2019.

United States 5-MeO-MALT is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

5-MeO-MALT

Bron en licentie